As of 2025-03-15, the Relative Valuation of TherapeuticsMD Inc (TXMD) is (0.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.74 USD, the upside of TherapeuticsMD Inc based on Relative Valuation is -194.7%.
The range of the Relative Valuation is (0.29) - (1.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.0x - 3.6x | 2.3x |
| Forward P/E multiples | 1.0x - 4.1x | 2.6x |
| Fair Price | (0.29) - (1.04) | (0.70) |
| Upside | -139.8% - -241.3% | -194.7% |
| Date | P/E |
| 2025-03-13 | -2.56 |
| 2025-03-12 | -2.68 |
| 2025-03-11 | -2.65 |
| 2025-03-10 | -2.78 |
| 2025-03-07 | -3.03 |
| 2025-03-06 | -2.99 |
| 2025-03-05 | -3.02 |
| 2025-03-04 | -3.03 |
| 2025-03-03 | -3.01 |
| 2025-02-28 | -3.23 |
| 2025-02-27 | -3.03 |
| 2025-02-26 | -2.97 |
| 2025-02-25 | -3.30 |
| 2025-02-24 | -3.48 |
| 2025-02-21 | -4.52 |
| 2025-02-20 | -3.51 |
| 2025-02-19 | -3.55 |
| 2025-02-18 | -3.55 |
| 2025-02-14 | -3.58 |
| 2025-02-13 | -3.58 |
| 2025-02-12 | -3.51 |
| 2025-02-11 | -3.48 |
| 2025-02-10 | -3.51 |
| 2025-02-07 | -3.55 |
| 2025-02-06 | -3.51 |
| 2025-02-05 | -3.55 |
| 2025-02-04 | -3.44 |
| 2025-02-03 | -3.58 |
| 2025-01-31 | -3.76 |
| 2025-01-30 | -3.76 |
| 2025-01-29 | -3.76 |
| 2025-01-28 | -3.79 |
| 2025-01-27 | -4.03 |
| 2025-01-24 | -4.00 |
| 2025-01-23 | -3.76 |
| 2025-01-22 | -3.62 |
| 2025-01-21 | -3.65 |
| 2025-01-17 | -3.69 |
| 2025-01-16 | -3.62 |
| 2025-01-15 | -3.86 |
| 2025-01-14 | -3.47 |
| 2025-01-13 | -3.62 |
| 2025-01-10 | -3.82 |
| 2025-01-08 | -3.86 |
| 2025-01-07 | -3.96 |
| 2025-01-06 | -4.36 |
| 2025-01-03 | -5.11 |
| 2025-01-02 | -5.46 |
| 2024-12-31 | -2.99 |
| 2024-12-30 | -3.58 |